Ancient Andeans Had Novel Genetic Advantages to Adapt to Altitude

Unlike other populations living at high altitude, Andeans didn’t rely on hypoxia-related genes.

Written byAshley Yeager
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: Lake Titicaca is where the ancient Andean samples were found.
© ISTOCK.COM, FILROM

Genes related to starch digestion, heart health, and immunity may have helped ancient Andean populations survive at high altitudes, researchers reported Wednesday (October 17) at the American Society of Human Genetics annual meeting in San Diego.

Previous work has shown that populations in Tibet, for instance, have specific gene variants that help them metabolize oxygen and also safeguard them against vitamin D deficiency. Studies of Ethiopians also show genetic adaptations to survive hypoxic, or low-oxygen, levels at high altitudes. “In the Andes, we don’t see anything like that,” says John Lindo, an anthropologist at Emory University in Atlanta, referring to prior investigations of Andean genetic characteristics. “People are really curious as to how they adapted to high altitude if we can’t find this genetic component.”

To search for such genetic adaptations, Lindo and his colleagues acquired the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies